LEV PHARMACEUTICALS
Lev Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Its products include C1-INH that is used for the treatment of hereditary angioedema. The company was founded in 2003 and is based in New York, New York. As of October 21, 2008, Lev Pharmaceuticals, Inc. operates as a subsidiary of ViroPharma Inc.
LEV PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
New York, New York, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
41 M USD
Similar Organizations
Resolvyx Pharmaceuticals
Resolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases.
Current Employees Featured
Founder
Investors List
Mast Capital Management
Mast Capital Management investment in Venture Round - Lev Pharmaceuticals
Alexandra Investment Management
Alexandra Investment Management investment in Venture Round - Lev Pharmaceuticals
Rosalind Capital Partners
Rosalind Capital Partners investment in Venture Round - Lev Pharmaceuticals
Emigrant Capital
Emigrant Capital investment in Venture Round - Lev Pharmaceuticals
Southpoint Capital Advisors
Southpoint Capital Advisors investment in Venture Round - Lev Pharmaceuticals
Hound Partners
Hound Partners investment in Venture Round - Lev Pharmaceuticals